C07D 515/02
In which the condensed system contains two hetero rings
Official title: in which the condensed system contains two hetero rings
C07D515/02 (In which the condensed system contains two hetero rings) appears on 92 US grants and 122 published applications in this corpus.
Search patents in C07D- Granted patents
- 92
- Published applications
- 122
- Assignees
- 94
- Inventors
- 568
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 4 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 0 |
| 2003 | 3 | 1 |
| 2004 | 1 | 3 |
| 2005 | 2 | 0 |
| 2006 | 1 | 3 |
| 2007 | 2 | 2 |
| 2008 | 1 | 2 |
| 2009 | 1 | 1 |
| 2010 | 1 | 2 |
| 2011 | 2 | 5 |
| 2012 | 0 | 1 |
| 2013 | 2 | 7 |
| 2014 | 9 | 3 |
| 2015 | 2 | 4 |
| 2016 | 2 | 6 |
| 2017 | 8 | 8 |
| 2018 | 4 | 9 |
| 2019 | 8 | 7 |
| 2020 | 2 | 7 |
| 2021 | 9 | 7 |
| 2022 | 6 | 5 |
| 2023 | 0 | 14 |
| 2024 | 4 | 10 |
| 2025 | 3 | 10 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Orexin receptor agonists and uses thereof29 Sep 2026US 12,747,252 B2Jazz Pharmaceuticals Ireland Limited
- Modulators of cystic fibrosis transmembrane conductance regulator28 Apr 2026US 12,612,416 B2Vertex Pharmaceuticals Incorporated
- Hybrid cyclic libraries and screens thereof3 Mar 2026US 12,565,518 B2The Johns Hopkins University
- NRF2-activating compound17 Feb 2026US 12,552,757 B2Senju Pharmaceutical Co., Ltd.
- Cystic fibrosis transmembrane conductance regulator modulating agents23 Sep 2025US 12,421,251 B2Vertex Pharmaceuticals Incorporated
- Novel compound or salt thereof, catalyst, method of preparing novel compound or salt thereof and method of preparing mannich product8 Oct 2026US 2026/0308178 A1Okinawa Institute of Science and Technology School Corporation
- Compounds for treating cancer16 Jul 2026US 2026/0200943 A1Genesis Therapeutics, Inc.
- Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof26 Mar 2026US 2026/0085067 A1Boundless Bio, Inc.
- Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of Cancer12 Feb 2026US 2026/0042754 A1Nodus Oncology Limited
- Modulators of cystic fibrosis transmembrane conductance regulator6 Nov 2025US 2025/0340574 A1Vertex Pharmaceuticals Incorporated
Most cited
By later US patents
- Fluorescent complex and lighting system using the same39US 7,902,741 B2Kabushiki Kaisha Toshiba · 2011
- Hybrid cyclic libraries and screens thereof36US 9,250,237 B2The Johns Hopkins University · 2016
- Phenylene alkyne matrix metalloproteinase inhibitors27US 6,849,648 B2Warner-Lambert Company · 2005
- Macrocyclics pyrimidines as aurora kinase inhibitors18US 8,815,872 B2Merck Patent GmbH · 2014
- Process for preparing .beta.-lactam derivative and synthetic intermediate9US 5,589,592 ATanabe Seiyaku Co., Ltd. · 1996